Trimeris (TRMS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Trimeris (TRMS)

An SI Board Since September 1997

Posts	SubjectMarks	Bans	Symbol
108	16	0	TRMS

Emcee: David S.	Type: Unmoderated

Introduction Market Data Compact

TRMS is a biotech firm engaged in the development of theraputic agents that block viral infection by inhibiting viral fusion with host cells. Their lead product candidate (T-20), inhibits fusion of HIV-1 with host cells. T-20 has been tested in a Phase I/II trial as a MONOTHERAPY for HIV infected patients in the US. Besides being safe & well-tolerated, the 4 patients in the trial who received the higest dose experienced a reduction in viral load to below detectable levels with an assay sensitivity of 500 copies/ml. - (twice as sensitive as the assay Agouron used in their FDA filing). Work will also examine T-20 for use in combination with approved drugs for treatment of HIV. Trimeris also has drug candidates for Respitory Syncytial Virus & Human Parainfluenza Virus.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
108	Looks like the start of a bull run. Low float, 15m, heavy short interest and go	Hal	-	4/18/2007
107	Leg: Trimeris Upgrading to Hold...For Now	mopgcw	-	7/20/2004
106	GS: Trimeris, Inc. EPS (FY Dec) 2004E ($1.07), 2005E $0.10 Outperform/Neutral (T	mopgcw	-	6/3/2004
105	08:31 TRMS Trimeris upped to Buy from Neutral at First Albany (14.30 ) Firs	Doc Bones	-	4/21/2004
104	Thoughts on this release? Stock suffering on a bad day: >>NUTLEY, N.J. &	tuck	-	2/19/2002
103	You're welcome.	Ben Wa	-	11/3/2000
102	Thanks for that post. Mark.	Mark Doms	-	11/3/2000
101	TRMS: Q3 RESULTS AHEAD OF EXPECTATIONS 06:58am EST 3-Nov-00 Prudential Securiti	LLCF	-	11/3/2000
100	Phase III trials set to begin--better late than never. Trimeris and Roche to	Mark Doms	-	10/4/2000
99	Pluvia, interesting comments, but I read the links and I do not find reference t	Cacaito	-	10/1/2000
98	IMO TRMS was run up based on significantly overstated results from their Phase I	Pluvia	-	9/13/2000
97	Howard Hughes still lives there	Ben Wa	-	9/13/2000
96	Mark, <i>Thank goodness Pluvia (someone in Las Vegas) has caught a fundam	Pluvia	-	9/13/2000
95	I posted this as well on the Raging Bull board:	Mark Doms	-	9/13/2000
94	<i>Correct, but you do know why the blond accross the bar suddenly look mo	scoobypax	-	9/12/2000
93	Perhaps they were reacting to the beer and chili.	Ben Wa	-	9/12/2000
92	Incidently it is interesting to note TRMS refused to discuss these issues with u	Pluvia	-	9/12/2000
91	I think you and I have seriously confused everybody at this point.	Ben Wa	-	9/12/2000
90	<i>...so if you have some chili and a beer to wash it down with and let ou	Pluvia	-	9/12/2000
89	...so if you have some chili and a beer to wash it down with and let out a fart,	Ben Wa	-	9/12/2000
88	<i>you have an interesting conclusion. the analysis is IMO, overly simplis	Pluvia	-	9/12/2000
87	you have an interesting conclusion. the analysis is IMO, overly simplistic, how	Ben Wa	-	9/12/2000
86	<b>Clarification of The Anti-HIV cocktail Issue</b> 1. Use of an a	Pluvia	-	9/12/2000
85	<b>TRIMERIS T-20 DRUG TRIAL DESIGN FLAWED – RESULTS QUESTIONED</b>	Pluvia	-	9/12/2000
84	I hope your report addresses why the T-20 phase III trail is late in starting.	Mark Doms	-	9/12/2000

Go to reply# or date (mm/dd/yy):